New Pathways to Solve Worldwide Health and Wellness Challenges
The world is always changing. Drug discovery and commercialization must adapt to keep up. Nowhere is this clearer than in the evolving needs of the global healthcare community. New challenges such as swine flu cry for attention while the impact of age-old problems grow and spread. Caleco Pharma Corp. is designed to meet these challenges in two ways.
First we strive to identify and develop biopharmaceutical products and therapeutic regimens that are truly unique and represent important new advances in the therapeutic categories we focus on. At the same time we provide innovative healthcare professional and consumer education and communications programs that accelerate thebase of scientific and clinical knowledge that support the use of our products in the marketplace. This will ensure that our products reach their maximum clinical and commercial value as rapidly as possible
FORWARD-LOOKING STATEMENTS
In our website, certain materials include forward-looking statements within the meaning of section 27a of the securities act of 1933 (as amended) and section 21e of the securities exchange act of 1934 (as amended). All statements other than statements of historical facts, are forward-looking statements that are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined, and assumptions of management. Forward looking statements are generally, but not always, identified by the words “plan,” “anticipate,” “believe,” “estimate,” ”should,” ”expect” and similar expressions include our expectations and objectives regarding our future financial position, operating results and business strategy. There are no assurances that the United States Patents and Trademarks Office will grant Caleco Pharma Corp. (”Caleco”) a patent in connection with its current patent applications. In addition, there are no assurances that Caleco will be able to manufacture and produce its products; that its products will be effective; or it will be able to carry out any pre-clinical or clinical trials of its products. Caleco’s ability to implement its business plan is subject to its ability to obtain substantial financing, of which there are no assurances. Readers are cautioned not to place undue reliance on the forward-looking statements made in our website.
